社区获得性肺炎临床治愈后肺部持续炎症:18FDG-PET/CT证据
研究对22例CAP幸存者住院期和出院后30-45天行18FDG-PET/CT,68%(95%CI 45%-85%)出院后仍有残余FDG摄取增高灶;tPGA从急性期821.5(SD 1140.2)降至出院后80.0(SD 81.4)(P=.006),但仍高于28例匹配历史对照的-19.4(SD 5.9)(P<.001)。提示感染临床治愈后肺部炎症持续存在。
要点
- CAP临床治愈后30-45天,68%患者肺部仍有FDG摄取增高灶。
- 出院后tPGA较急性期显著下降(P=.006),但仍高于无肺炎对照(P<.001)。
- 持续肺部炎症可能解释CAP后心血管病和死亡风险增加。
核心结论
- 相当比例的CAP幸存者在感染临床治愈后仍存在肺部炎症活动增高的持续病灶。
- 该发现为CAP后观察到的发病率和死亡率增加提供了可能的机制解释。
研究设计与样本
- 对22例CAP幸存者在住院期(急性CAP)和出院后30-45天(post-CAP)行18FDG-PET/CT扫描。
- 视觉判读FDG摄取增高灶并计算总肺糖酵解活性(tPGA,经背景校正的总代谢活性)。
- post-CAP期与28例匹配的无肺炎历史对照者相似体积肺区域比较糖酵解活性。
主要发现
- 68%的CAP幸存者(95%CI 45%-85%)在post-CAP扫描中有 distinct 残余FDG摄取增高区域。
- tPGA从急性CAP期的821.5(SD 1140.2)降至post-CAP期的80.0(SD 81.4),P=.006。
- post-CAP期tPGA显著高于对照者相似体积肺区域:80.0(SD 81.4)vs -19.4(SD 5.9),P<.001。
临床怎么用
- CAP患者出院后即使临床治愈,仍应关注持续肺部炎症的潜在影响。
- 对CAP幸存者的随访管理可考虑炎症相关合并症的风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Survivors of community-acquired pneumonia (CAP) are at increased risk of cardiovascular disease, cognitive and functional decline, and death, but the mechanisms remain unknown. RESEARCH QUESTION: Do CAP survivors have evidence of increased inflammatory activity in their lung parenchyma on 2-deoxy-2-[18F]fluoro-d-glucose (18FDG)-PET/CT imaging after clinical resolution of infection? STUDY DESIGN AND METHODS: We obtained 18FDG-PET/CT scans from 22 CAP survivors during their hospitalization with pneumonia (acute CAP) and 30 to 45 days after hospital discharge (post-CAP). In each set of scans, we assessed the lungs for foci of increased 18FDG uptake by visual interpretation and by total pulmonary glycolytic activity (tPGA), a background-corrected measure of total metabolic activity (as measured by 18FDG uptake). We also measured, post-CAP, the glycolytic activity of CAP survivor lung areas with volumes similar to the areas in 28 matched historical control subjects without pneumonia. RESULTS: Overall, 68% of CAP survivors (95% CI, 45%-85%) had distinct residual areas of increased 18FDG uptake in their post-CAP studies. tPGA decreased from 821.5 (SD, 1,140.2) in the acute CAP period to 80.0 (SD, 81.4) in the post-CAP period (P = .006). The tPGA post-CAP was significantly higher than that in lung areas of similar volume in control subjects (80.0 [SD, 81.4] vs -19.4 [SD, 5.9]; P < .001). INTERPRETATION: An important proportion of CAP survivors have persistent pulmonary foci of increased inflammatory activity beyond resolution of their infection. As inflammation contributes to cardiovascular disease, cognitive decline, functional waning, and mortality risk in the general population, this finding provides a plausible mechanism for the increased morbidity and mortality that have been observed post-CAP.
引用
- Corrales-Medina VF, deKemp RA, Chirinos JA, et al. Persistent Lung Inflammation After Clinical Resolution of Community-Acquired Pneumonia as Measured by 18FDG-PET/CT Imaging. Chest. 2021. PMID: 33667494. doi:10.1016/j.chest.2021.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。